In summary, we demonstrated that catechol inhibits EMT, migration, invasion, anoikis resistance, and stem cell-like properties through EGFR-AKT-ERK signaling pathways in EGF-treated human HCC cells. This evidence concerns the gene EGF and hepatocellular carcinoma.